CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank86
5Y CAGR+70.3%
Year-over-Year Change
Enterprise value to sales ratio
5Y CAGR
+70.3%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
14.3x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 22.50 | -68.4% |
| 2024 | 71.21 | -75.9% |
| 2023 | 295.12 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 1.68 | +6.7% |
| 2020 | 1.57 | +18.4% |
| 2019 | 1.33 | +23.8% |
| 2018 | 1.07 | -1.8% |
| 2017 | 1.09 | -12.5% |
| 2016 | 1.25 | - |